These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8740972)

  • 61. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis.
    Meddows-Taylor S; Martin DJ; Tiemessen CT
    J Infect Dis; 1998 Apr; 177(4):921-30. PubMed ID: 9534964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages.
    Wuyts A; Schutyser E; Menten P; Struyf S; D'Haese A; Bult H; Opdenakker G; Proost P; Van Damme J
    Biochemistry; 2000 Nov; 39(47):14549-57. PubMed ID: 11087410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neutrophil receptors for interleukin-8 and related CXC chemokines.
    Murphy PM
    Semin Hematol; 1997 Oct; 34(4):311-8. PubMed ID: 9347581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.
    Khandaker MH; Xu L; Rahimpour R; Mitchell G; DeVries ME; Pickering JG; Singhal SK; Feldman RD; Kelvin DJ
    J Immunol; 1998 Aug; 161(4):1930-8. PubMed ID: 9712063
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutrophil-activating peptide ENA-78.
    Walz A; Strieter RM; Schnyder S
    Adv Exp Med Biol; 1993; 351():129-37. PubMed ID: 7942291
    [No Abstract]   [Full Text] [Related]  

  • 66. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids.
    Clark-Lewis I; Dewald B; Loetscher M; Moser B; Baggiolini M
    J Biol Chem; 1994 Jun; 269(23):16075-81. PubMed ID: 8206907
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hamycin inhibits IL-8-induced biologic response by modulating its receptor in human polymorphonuclear neutrophils.
    Manna SK; Samanta S; Samanta AK
    J Immunol; 1997 Nov; 159(10):5042-52. PubMed ID: 9366432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 1H NMR studies of interleukin 8 analogs: characterization of the domains essential for function.
    Rajarathnam K; Clark-Lewis I; Sykes BD
    Biochemistry; 1994 May; 33(21):6623-30. PubMed ID: 8204599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Staurosporine restores signaling and inhibits interleukin-8-induced chemotactic desensitization.
    Johnston JA; Ferris DK; Wang JM; Longo DL; Oppenheim JJ; Kelvin DJ
    Eur J Immunol; 1994 Oct; 24(10):2556-62. PubMed ID: 7925583
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interferon-gamma maintains the binding and functional capacity of receptors for IL-8 on cultured human T cells.
    Tani K; Su SB; Utsunomiya I; Oppenheim JJ; Wang JM
    Eur J Immunol; 1998 Feb; 28(2):502-7. PubMed ID: 9521059
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes.
    Bonecchi R; Facchetti F; Dusi S; Luini W; Lissandrini D; Simmelink M; Locati M; Bernasconi S; Allavena P; Brandt E; Rossi F; Mantovani A; Sozzani S
    J Immunol; 2000 Apr; 164(7):3862-9. PubMed ID: 10725748
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.
    Luu NT; Rainger GE; Nash GB
    J Immunol; 2000 Jun; 164(11):5961-9. PubMed ID: 10820279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration.
    Campbell JJ; Foxman EF; Butcher EC
    Eur J Immunol; 1997 Oct; 27(10):2571-8. PubMed ID: 9368612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular modeling of interleukin-8 receptor beta and analysis of the receptor-ligand interaction.
    Luo Z; Butcher DJ; Huang Z
    Protein Eng; 1997 Sep; 10(9):1039-45. PubMed ID: 9464567
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interleukin-8 antagonists generated by N-terminal modification.
    Moser B; Dewald B; Barella L; Schumacher C; Baggiolini M; Clark-Lewis I
    J Biol Chem; 1993 Apr; 268(10):7125-8. PubMed ID: 8463247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor.
    Fernando H; Chin C; Rösgen J; Rajarathnam K
    J Biol Chem; 2004 Aug; 279(35):36175-8. PubMed ID: 15252057
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polyoxygenated dysidea sterols that inhibit the binding of [I125] IL-8 to the human recombinant IL-8 receptor type A.
    de Almeida Leone P; Redburn J; Hooper JN; Quinn RJ
    J Nat Prod; 2000 May; 63(5):694-7. PubMed ID: 10843593
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment.
    Gangavarapu P; Rajagopalan L; Kolli D; Guerrero-Plata A; Garofalo RP; Rajarathnam K
    J Leukoc Biol; 2012 Feb; 91(2):259-65. PubMed ID: 22140266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.
    Hébert CA; Vitangcol RV; Baker JB
    J Biol Chem; 1991 Oct; 266(28):18989-94. PubMed ID: 1918013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.
    Mayo KH; van der Schaft DW; Griffioen AW
    Angiogenesis; 2001; 4(1):45-51. PubMed ID: 11824378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.